UCLA Gets $11.6M in NCI Funding for Prostate Cancer Program | GenomeWeb

NEW YORK (GenomeWeb News) – The University of California Los Angeles said today that its Jonsson Comprehensive Cancer Center (JCCC) and David Geffen School of Medicine have received $11.6 million from the National Cancer Institute to fuel a range of molecular research projects focused on prostate cancer.

The award continues providing funding for the center and the medical school to serve as a Specialized Program of Research Excellence (SPORE) for five years. It is the third grant they have received to fund this SPORE.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Pacific Biosciences is hosting a competition in which researchers are vying to win free sequencing for an organism with the most interesting genome.

An opinion piece appearing in Newsday likens familial DNA searches to stop-and-frisk policies.

The San people of Africa have drawn up a code of conduct for researchers, according to the Conversation.

In Nature this week: genotypes linked to hip osteoarthritis, and more.

Mar
28
Sponsored by
Illumina

This webinar describes the optimization and validation of two commercially available next-generation sequencing assays that may be used to guide personalized cancer treatment. 

Apr
11
Sponsored by
Personal Genome Diagnostics

This webinar will provide an overview of genomic alterations that play a role in immunotherapy response.

May
04
Sponsored by
Qiagen

This online seminar will provide an overview of the use of liquid biopsies for cancer recurrence monitoring with a particular focus on colorectal cancer.

May
23
Sponsored by
Agilent Technologies

This webinar will discuss a target enrichment workflow for high-confidence detection of variants.